StemPro™ Chondrogenesis Differentiation Kit
StemPro™ Chondrogenesis Differentiation Kit
Gibco™

StemPro™ Chondrogenesis Differentiation Kit

StemPro® Chondrogenesis Differentiation Kit는 조직 배양 용기에서 중간엽 줄기세포(MSC)의 연골 분화를 위해 개발되었습니다. 이 kit에는 MSC가 연골형성 경로에 기여하여 연골세포를자세히 알아보기
Have Questions?
카탈로그 번호수량
A10071011 Kit
카탈로그 번호 A1007101
제품 가격(KRW)
295,000
온라인 행사
Ends: 31-Dec-2025
327,000
할인액 32,000 (10%)
Each
카트에 추가하기
수량:
1 Kit
제품 가격(KRW)
295,000
온라인 행사
Ends: 31-Dec-2025
327,000
할인액 32,000 (10%)
Each
카트에 추가하기
StemPro® Chondrogenesis Differentiation Kit는 조직 배양 용기에서 중간엽 줄기세포(MSC)의 연골 분화를 위해 개발되었습니다. 이 kit에는 MSC가 연골형성 경로에 기여하여 연골세포를 생성하도록 하는데 필요한 모든 시약이 들어있습니다. StemPro® Chondrogenesis Differentiation Kit와 StemPro® MSC SFM 또는 MesenPRO RS™ Medium 를 함께 사용하여 MSC 분리, 확장, 콜라겐 매트릭스 생성 연골세포 분화에 대한 표준 배양 작업액을 만들 수 있습니다.
For Research Use Only. Not for use in diagnostic procedures.
사양
세포 유형Stem Cells (Mesenchymal)
배양 환경CO2
엔도톡신 수준≤50 EU/mL, ≤ 50 EU/ml
형식Liquid
글루코스Low Glucose
글루타민GlutaMAX™-I
HEPES 버퍼No HEPES
페놀 레드 인디케이터No Phenol Red
순도 또는 품질 등급Research Grade
수량1 Kit
연구 카테고리Differentiation
혈청 수준Serum-Free
Sodium Bicarbonate 버퍼Sodium Bicarbonate
Sodium Pyruvate 첨가제Sodium Pyruvate
Human
용도(애플리케이션)Stem Cell Differentiation
제품라인Gibco, StemPro
제품 유형Chondrogenesis Differentiation Kit
Unit SizeEach
구성 및 보관
This kit is shipped with a 100 ml basal medium and 10 ml growth supplement adequate to formulate 100 ml of complete medium. Components require separate shipping and storage requirements. The growth supplement is not sold individually.
StemPro™ Osteocyte⁄Chondrocyte Differentiation Basal Medium 2 to 8°C (protect from light)
StemPro™ Chondrogenesis Supplement -5 to -20°C (in the dark)

자주 묻는 질문(FAQ)

How many times can I freeze/thaw the StemPro Chondrogenesis Supplement (Cat. No. A1006401) from the StemPro Chondrogenesis Differentiation Kit (Cat. No. A1007101)?

We do not recommend that you freeze/thaw the StemPro Chondrogenesis Supplement (Cat. No. A10064-01) from the StemPro Chondrogenesis Differentiation Kit (Cat. No. A1007101). Addition of supplement to the StemPro Osteocyte/Chondrocyte Differentiation Basal Medium (Cat. No. A1006901) is stable at 2-8 degrees C for up to 1 month, protected from light.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

What mesenchymal stem cells (MSC) sources can I use with the StemPro Chondrogenesis Differentiation Kit (Cat. No. A1007101)?

The StemPro Chondrogenesis Differentiation Kit (Cat. No. A1007101) was designed and tested using human adipose-derived stem cells (ADSC). Based on protocols in literature, it should also work with mesenchymal stem cells (MSC) from other sources, including umbilical cord and cord blood.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

The StemPro Chondrogenesis Differentiation Kit manual refers to MSC Attachment Medium under Chondrogenesis Differentiation, Step 7. Is MSC Attachment Medium the same as MSC growth medium?

Yes, MSC Attachment Medium is the same as MSC growth medium.

What kinds of growth factors are used in mesenchymal stem cell (MSC) research?

Growth factors used for MSC maintenance and self-renewal: LIF, FGF-basic, EGF, HGF, PDGF, and Wnt3.

Growth factors or cytokines for MSC differentiation: BMP-2and TGF-β1.

(Arthritis Res Ther 9:204 (2007)

View our Gibco™ MSC research products.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

How can I culture mesenchymal stem cells (MSCs) in vitro?

MSCs may be cultured in either serum-containing medium or serum-free medium. The standard culturing conditions are DMEM, low glucose with 10% FBS. MSCs can also be grown in reduced-serum (2%) Gibco MesenPRO RS Medium (Cat. No. 12746-012), or in serum-free Gibco StemPro MSC SFM XenoFree Medium (Cat. No. A10675) and Gibco StemPro MSC SFM (Cat. No. A10332). In general, MSCs grow better under hypoxic conditions (2% O2).

인용 및 참조 문헌 (2)

인용 및 참조 문헌
Abstract
Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I.
Authors:Wang W, Nyman JS, Ono K, Stevenson DA, Yang X, Elefteriou F,
Journal:Hum Mol Genet
PubMed ID:21757497
Mutations in NF1 cause neurofibromatosis type I (NF1), a disorder characterized, among other clinical manifestations, by generalized and focal bony lesions. Dystrophic scoliosis and tibial pseudoarthrosis are the most severe skeletal manifestations for which treatment is not satisfactory, emphasizing the dearth of knowledge related to the biology of NF1 in ... More
Human Synovial MSC Good Manufacturing Practices for Articular Cartilage Regeneration.
Authors:Fernandes TL, Kimura HA, Pinheiro CCG, Shimomura K, Nakamura N, Ferreira JRM, Gomoll AH, Hernandez AJ, Bueno DF,
Journal:Tissue Eng Part C Methods
PubMed ID:30412046
cartilage restoration is a desperately needed bridge for patients with symptomatic cartilage lesions. Chondral lesion is a pathology with high prevalence, reaching as much as 63% of general population and 36% among athletes. Despite Autologous Chondrocyte Implantation (ACI) versatility, it still fails to fully reproduce hyaline articular cartilage characteristics. Mesenchymal ... More